by | Oct 8, 2026 | Medication Decisions
A recent prospective study from Switzerland followed 32 primary-care patients as they reduced antidepressants. The study adds useful evidence that symptom increases can cluster around dose changes. It also makes something else plain: measuring withdrawal is difficult...
by Teralyn Sell, PhD | Oct 1, 2026 | Human Performance, Medication Decisions
A psychiatric medication review can become a very small conversation: Are you doing okay? Any side effects? Need a refill? That may be enough to keep a prescription moving. It is rarely enough to determine whether the medication still makes sense. A February 2026...
by | Sep 24, 2026 | Medication Decisions
Psychiatric medication reviews are getting more attention. That is a good thing, with one important caveat: a review can become another administrative ritual. In February 2026, an American Society of Clinical Psychopharmacology task force published consensus...
by Teralyn Sell, PhD | Sep 17, 2026 | Medication Decisions
A psychiatric medication can be appropriate to start and still deserve a serious reassessment later. That should not be a controversial statement. It is simply how good decisions work when circumstances change. In February 2026, a 45-member international task force...
by Teralyn Sell, PhD | Sep 12, 2026 | Medication Decisions
Psychiatric medications are often started through a decision. They are continued through momentum. That is not an accusation. It is how most health care systems work. A prescription has refills. A follow-up visit is short. The immediate question becomes, “Should we...
